Skip to main content
Vyome Holdings, Inc logo

Vyome Holdings, Inc — Investor Relations & Filings

Ticker · HIND ISIN · US67424L2097 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2022-06-23 Capital/Financing Update
Country US United States of America
Listing US HIND

About Vyome Holdings, Inc

https://www.reshapelifesciences.com/oba…

Vyome Holdings, Inc. is a clinical-stage biotechnology company focused on developing a portfolio of assets for immuno-inflammatory and potential orphan diseases. The company utilizes an artificial intelligence (AI)-driven platform to accelerate its research and development pipeline. Its operations are structured to leverage innovation and R&D capabilities across both the United States and India.

Recent filings

Filing Released Lang Actions
8-K Filing
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 16, 2022, by ReShape Lifesciences Inc. It reports the entry into a material definitive agreement involving the exercise of warrants and issuance of new warrants, including details about the terms, proceeds, and related fees. The content focuses on financing activities, specifically a private placement and warrant exercise agreement, which are capital raising events. There are no financial statements or comprehensive financial performance data included, nor is this an announcement of a report publication. The document fits the category of Capital/Financing Update (CAP) as it details financing transactions and capital structure changes.
2022-06-23 English
4 Filing
Director's Dealing
2022-06-06 English
4 Filing
Director's Dealing
2022-06-06 English
4 Filing
Director's Dealing
2022-06-01 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release announcing financial results for the quarter ended March 31, 2022. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes a press release as an exhibit. The length is 3821 characters, which is relatively short and consistent with a current report announcing earnings results rather than the full earnings release or quarterly report itself. According to the classification rules, initial announcements of quarterly financial results (key highlights only) are classified as Earnings Release (ER). Since this is a Form 8-K announcing quarterly financial results via a press release, the appropriate classification is Earnings Release (ER).
2022-05-23 English
10-Q Filing
Interim / Quarterly Report Q1 2022
2022-05-23 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.